Featured Research

from universities, journals, and other organizations

Vaginally administered erectile dysfunction medication may alleviate menstrual cramping, study suggests

Date:
December 5, 2013
Source:
Penn State
Summary:
Women with moderate to severe menstrual cramps may find relief in a class of erectile dysfunction drugs, according to a team of researchers.

Sildenafil citrate, sold under the brand name Viagra, may help with pelvic pain because it can lead to dilation of the blood vessels.
Credit: Penn State

Women with moderate to severe menstrual cramps may find relief in a class of erectile dysfunction drugs, according to a team of researchers led by Penn State College of Medicines Richard Legro.

Primary dysmenorrhea, also called PD, is the most common cause of pelvic pain in women. The current treatment is non-steroidal anti-inflammatory drugs, such as ibuprofen. However, ibuprofen does not work well for all women, and can be associated with ulcers and kidney damage when used chronically as it often is for PD.

Sildenafil citrate, sold under the brand name Viagra, may help with pelvic pain because it can lead to dilation of the blood vessels. Previous research shows that taking it orally can alleviate pelvic pain, but the incidence of side effects -- often headaches -- may be too high for routine use.

The researchers looked at administering sildenafil citrate vaginally, which had not yet been tried, to treat PD. They compared pain relief fromuse of sildenafil vaginally with that of a placebo. Results were published in Human Reproduction.

Penn State College of Medicine researchers worked with researchers at Nova Gradiska General Hospital in Croatia. They recruited women 18 to 35 years old who suffered from moderate to severe PD. Of the 29 women screened for the study, 25 were randomized to receive either sildenafil or a placebo drug.

Patients rated their pain over four consecutive hours. Sildenafil citrate administered vaginally alleviates acute menstrual pain with no reported side effects. Researchers hypothesized that the drug would alleviatepain, which it does, but also that is does so by increasing blood flow. However, because uterine blood flow increased from both sildenafil and the placebo, the reason it alleviates pain is not yet known.

"If future studies confirm these findings, sildenafil may become a treatment option for patients with PD," said Legro, professor of obstetrics and gynecology and public health sciences. "Since PD is a condition that most women suffer from and seek treatment for at some points in their lives, the quest for new medication is justified."

Larger studies must be completed to validate the small sample of this study, and additional research is needed to see whether sildenafil changes the menstrual bleeding pattern.


Story Source:

The above story is based on materials provided by Penn State. Note: Materials may be edited for content and length.


Journal Reference:

  1. R. Dmitrovic, A. R. Kunselman, R. S. Legro. Sildenafil citrate in the treatment of pain in primary dysmenorrhea: a randomized controlled trial. Human Reproduction, 2013; 28 (11): 2958 DOI: 10.1093/humrep/det324

Cite This Page:

Penn State. "Vaginally administered erectile dysfunction medication may alleviate menstrual cramping, study suggests." ScienceDaily. ScienceDaily, 5 December 2013. <www.sciencedaily.com/releases/2013/12/131205171817.htm>.
Penn State. (2013, December 5). Vaginally administered erectile dysfunction medication may alleviate menstrual cramping, study suggests. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/12/131205171817.htm
Penn State. "Vaginally administered erectile dysfunction medication may alleviate menstrual cramping, study suggests." ScienceDaily. www.sciencedaily.com/releases/2013/12/131205171817.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins